Brainstorm Cell (BCLI)

$0.84 -0.33 (-28.21%)
Market Cap 11.51M
Revenue (ttm) 0.00
Net Income (ttm) -11.62M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.16
Volume 819,600
Avg Vol 1,676,626
Day's Range N/A - N/A
Shares Out 9.84M
Stochastic %K 34%
Beta 0.22
Analysts Strong Sell
Price Target $7.50

Company Profile

Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company's NurOwn proprietary cell therapy platform that leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance...

Industry: Biotechnology
Sector: Healthcare
Phone: 201 488 0460
Address:
1325 Avenue of Americas, 28th Floor, New York, United States
ALSCellTherapy
ALSCellTherapy Aug. 19 at 3:55 PM
$BCLI Garden-variety pull back here! Very normal and expected after a big run back up. Maybe a little pause and pull back before some material news and annoucements. Very healthy.
0 · Reply
Knuckles30
Knuckles30 Aug. 19 at 3:17 PM
$BCLI Nothing but fucking games with this stock Where is the jolly jerkoff today with his pom poms
1 · Reply
Pipemajors82
Pipemajors82 Aug. 19 at 1:41 PM
$BCLI hoping they Tie CP and Ph3B together as proof NurOwn works. Think its oretty hard to get AA on CP alone.
1 · Reply
Strout100
Strout100 Aug. 19 at 1:39 PM
$BCLI Peter Pitts to lead 3b endurance trials under special protecals granted by the FDA. I believe Pitts knows bcli was railroad ed by past FDA executives, Peter Marks and Janet woodbitch, they seem to have some type of funding source, we should know shortly. My bet is with Pitts. Listening to some of his past interviews, he is as sharp and experienced as you can get! This hits 2 plus bucks in the next few weeks if not sooner🤞🤞
0 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Aug. 19 at 1:14 PM
$BCLI love bio so hard
0 · Reply
funnymoney90210
funnymoney90210 Aug. 19 at 3:46 AM
$BCLI scam
0 · Reply
Doola20022
Doola20022 Aug. 19 at 2:06 AM
$BCLI this thing is crazy
0 · Reply
uieriwer
uieriwer Aug. 19 at 12:27 AM
$BCLI so is funding even enough for this thing with its track record?
1 · Reply
ALSCellTherapy
ALSCellTherapy Aug. 18 at 8:27 PM
$BCLI $1.41 on 211,792 in volume!!!
0 · Reply
afc2881
afc2881 Aug. 18 at 7:26 PM
$BCLI
0 · Reply
Latest News on BCLI
No data available.
ALSCellTherapy
ALSCellTherapy Aug. 19 at 3:55 PM
$BCLI Garden-variety pull back here! Very normal and expected after a big run back up. Maybe a little pause and pull back before some material news and annoucements. Very healthy.
0 · Reply
Knuckles30
Knuckles30 Aug. 19 at 3:17 PM
$BCLI Nothing but fucking games with this stock Where is the jolly jerkoff today with his pom poms
1 · Reply
Pipemajors82
Pipemajors82 Aug. 19 at 1:41 PM
$BCLI hoping they Tie CP and Ph3B together as proof NurOwn works. Think its oretty hard to get AA on CP alone.
1 · Reply
Strout100
Strout100 Aug. 19 at 1:39 PM
$BCLI Peter Pitts to lead 3b endurance trials under special protecals granted by the FDA. I believe Pitts knows bcli was railroad ed by past FDA executives, Peter Marks and Janet woodbitch, they seem to have some type of funding source, we should know shortly. My bet is with Pitts. Listening to some of his past interviews, he is as sharp and experienced as you can get! This hits 2 plus bucks in the next few weeks if not sooner🤞🤞
0 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Aug. 19 at 1:14 PM
$BCLI love bio so hard
0 · Reply
funnymoney90210
funnymoney90210 Aug. 19 at 3:46 AM
$BCLI scam
0 · Reply
Doola20022
Doola20022 Aug. 19 at 2:06 AM
$BCLI this thing is crazy
0 · Reply
uieriwer
uieriwer Aug. 19 at 12:27 AM
$BCLI so is funding even enough for this thing with its track record?
1 · Reply
ALSCellTherapy
ALSCellTherapy Aug. 18 at 8:27 PM
$BCLI $1.41 on 211,792 in volume!!!
0 · Reply
afc2881
afc2881 Aug. 18 at 7:26 PM
$BCLI
0 · Reply
afc2881
afc2881 Aug. 18 at 7:24 PM
$BCLI Volume is blowing up. Went from 105k to 180k in a few minutes!
1 · Reply
Strout100
Strout100 Aug. 18 at 6:11 PM
$BCLI Didn't the FDA make guidelines streamline for 3b, so it doesn't drag out forever? As I recall the blinded side was to be unfolded and given actual nurown once they completed the blind side test. Not sure been so long since guidelines were announced. It did seem FDA was trying to make it much more favorable for better results, which means nobody with scores below alsfsr scores below 35! Pitts is our man, he knows FDA inside and out first hand.
1 · Reply
Giggsy_Bing
Giggsy_Bing Aug. 18 at 5:38 PM
$BCLI the May warrants exercise price is $1.45…if this can hold above that and touch around $2 watch for those warrants to be exercised. Would create funding for the company, but simultaneously dilute current shareholders.
1 · Reply
DoctorJT
DoctorJT Aug. 18 at 5:37 PM
$BCLI funny how Chaim was handed an epic winner on a silver platter (literally), screwed it up, and hasn’t been able to get it over the finish line, and we’re sitting today at a 15M MC. We all know NurOwn works. Yet, two young, naive, college students (Amylyx) with what ultimately became a failed ALS failed drug in trials and didn’t work at all, today sits at 3.73B MC. We clearly all picked the wrong pony. Will Chaim be able to correct his horrible and embarrassing CEO performance, thus far?! We shall see.
1 · Reply
afc2881
afc2881 Aug. 18 at 4:36 PM
$BCLI Something definitely going on behindvthe scenes 🚀
4 · Reply
afc2881
afc2881 Aug. 18 at 4:35 PM
$BCLI
0 · Reply
ALSCellTherapy
ALSCellTherapy Aug. 18 at 4:33 PM
$BCLI Must have funding and announcements in bound!!!
0 · Reply
ALSCellTherapy
ALSCellTherapy Aug. 18 at 4:31 PM
$BCLI Holy sheeet! Price is rising and fast!
0 · Reply
ALSCellTherapy
ALSCellTherapy Aug. 18 at 3:29 PM
$BCLI Bid Ask continuing to firm and tighten. Seems the trend continues to be up and positive again.
2 · Reply
ALSCellTherapy
ALSCellTherapy Aug. 18 at 3:13 PM
$BCLI I reread the most recent press release. What continues to stand out to me is that in all previous press releases it emphasized funding funding funding and now it isn't even mentioned...this is very positively suspicious that they already have major funding or it is known the major funding is coming...
1 · Reply
SilentBull69
SilentBull69 Aug. 18 at 1:10 PM
$AMLX $BCLI 💥💥💥AMLX is on fire💥💥💥 The data shows a spectacular, home-run Phase 3 LUCIDITY trial result that completely exceeded Wall Street's wildest expectations The official data points are HISTORIC ***The Primary Endpoint Met (A 55% Reduction): The trial demonstrated a staggering 55% reduction in severe hypoglycemic events compared to placebo💥💥 and completely crushed its regulatory targets ***The Statistical P-Value is Irrefutable: The primary endpoint hit an astronomical mathematical significance level of p=0.000003. In clinical data, that is an ABSOLUTE lock💥💥 ***It means there is virtually ZERO chance this data is a fluke, and the FDA's regulatory path is completely CLEAR ***NDA Set for Year-End💥💥 Management officially confirmed they are submitting the NDA to the FDA by the end of this year, backed by their existing Breakthrough Therapy and Orphan Drug Designations🎯 Commercial launch preparations are fully underway……with 250 Mill in CASH IN-HAND 💥💥💥😎
1 · Reply
DoctorJT
DoctorJT Aug. 18 at 5:13 AM
$BCLI while NurOwn is totally stalled, over at COYA, they may be hitting a “home run,” according to a top ALS neurologist. We shall see and only time will tell, but if Coya is as big as many think it could be, NurOwn may become obsolete within the next year, as Coya 302 may become the new SOC. https://stocktwits.com/zampy/message/661889770
2 · Reply